Aflac Incorporated $AFL Holdings Increased by CTC Alternative Strategies Ltd.

Posted by Brenda Bartman on Aug 1st, 2026

CTC Alternative Strategies Ltd. lifted its holdings in Aflac Incorporated (NYSE:AFL – Free Report) by 389.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,789 shares of the financial services provider’s stock after acquiring an additional 7,789 shares during the period. Aflac accounts for approximately 2.4% of CTC Alternative Strategies Ltd.’s holdings, making the stock its 8th biggest holding. CTC Alternative Strategies Ltd.’s holdings in Aflac were worth $1,074,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AFL. Vanguard Group Inc. raised its position in Aflac by 13.4% during the fourth quarter. Vanguard Group Inc. now owns 57,142,072 shares of the financial services provider’s stock valued at $6,301,056,000 after purchasing an additional 6,759,169 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Aflac by 1.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,550,855 shares of the financial services provider’s stock valued at $499,216,000 after purchasing an additional 67,650 shares during the last quarter. Norges Bank purchased a new position in shares of Aflac in the 4th quarter worth approximately $420,078,000. Amundi boosted its holdings in shares of Aflac by 22.6% in the 1st quarter. Amundi now owns 3,268,209 shares of the financial services provider’s stock worth $358,555,000 after purchasing an additional 603,426 shares during the period. Finally, First Trust Advisors LP increased its position in shares of Aflac by 161.9% during the 1st quarter. First Trust Advisors LP now owns 3,184,801 shares of the financial services provider’s stock valued at $349,405,000 after purchasing an additional 1,968,738 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

AFL stock opened at $127.53 on Friday. Aflac Incorporated has a twelve month low of $96.95 and a twelve month high of $130.22. The firm has a market cap of $64.91 billion, a price-to-earnings ratio of 14.48, a PEG ratio of 1.96 and a beta of 0.61. The business’s fifty day simple moving average is $119.64 and its two-hundred day simple moving average is $114.80. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.26.

Aflac (NYSE:AFL – Get Free Report) last issued its earnings results on Wednesday, April 29th. The financial services provider reported $1.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). The company had revenue of $4.24 billion for the quarter, compared to analysts’ expectations of $4.20 billion. Aflac had a net margin of 25.60% and a return on equity of 13.88%. The firm’s revenue for the quarter was up 27.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.66 earnings per share. Analysts predict that Aflac Incorporated will post 7.06 earnings per share for the current year.

Wall Street Analysts Forecast Growth

AFL has been the topic of several recent research reports. Piper Sandler restated an “overweight” rating and set a $130.00 price target (up from $125.00) on shares of Aflac in a report on Tuesday, May 26th. Barclays cut their price objective on shares of Aflac from $99.00 to $98.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 7th. Jefferies Financial Group reissued a “hold” rating and issued a $108.00 target price (up from $100.00) on shares of Aflac in a research note on Friday, July 10th. Wells Fargo & Company lifted their price target on shares of Aflac from $111.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 9th. Finally, Weiss Ratings upgraded shares of Aflac from a “buy (b+)” rating to a “buy (a-)” rating in a report on Thursday, July 23rd. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $116.17.

Read Our Latest Research Report on Aflac

Insider Transactions at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 12,370 shares of the company’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $116.54, for a total value of $1,441,599.80. Following the transaction, the director directly owned 33,310 shares in the company, valued at $3,881,947.40. This represents a 27.08% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Post Holdings Co. Ltd. Japan sold 27,845 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $116.71, for a total transaction of $3,249,789.95. Following the transaction, the insider directly owned 50,898,490 shares in the company, valued at approximately $5,940,362,767.90. This trade represents a 0.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 744,916 shares of company stock valued at $87,118,632 in the last quarter. 0.80% of the stock is currently owned by company insiders.

Aflac Profile

(Free Report)

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.